Dr. Haytham Hajjar

Dr. Haytham Hajjar

Healthcare executive with over 30 years of experience in hospital administration, health systems development, and strategic transformation.

Current PositionDr. Haytham Hajjar

Founder and Manager of Welgenome Company, integrating genomics, preventive medicine, and personalized wellness solutions.

Former Leadership & Professional Experience

He served for over a decade as Business Development Director at the Princess Al Jawhara Center for Molecular Medicine and Inherited Disorders, Arabian Gulf University, Bahrain, leading service expansion and accreditation initiatives.

He previously held executive leadership roles at Al Ahli Hospital (Qatar), Gulf Diabetes Specialist Center (Bahrain), and Al Salam Hospital (Kuwait).

He also served as Director General of the Lebanese Red Cross, leading post-war institutional restructuring and modernization initiatives.

Areas of Expertise
  • Hospital Administration
  • Business Development
  • Health Systems Reform
  • Strategic Planning
  • Molecular Medicine Integration
  • Accreditation & Quality Systems
Publications & Academic Contributions

Academic lecturer and training coordinator at the American University of Beirut and University of Balamand.

Advisory Roles & Professional Affiliations
  • Consultant roles with WHO, UNICEF, World Bank, and Islamic Development Bank
  • Lifelong Member, International Epidemiologic Association
  • Founding Member, Lebanese Health Management Association
Education
  • Doctorate in Holistic Natural Health & Healing – College of Natural Health, USA
  • Master of Public Health (Hospital & Health Services Administration)
  • BSc in Biology–Chemistry – American University of Beirut

 

Other News

Egypt’s Universal Health Insurance System Now Covers 69.5 Million Beneficiaries

Egypt’s Universal Health Insurance System Now Covers 69.5 Million Beneficiaries

July 14, 2026
🇪🇬 Egypt’s Healthcare Achievements Briefed to Ambassadors Minister o
World’s First Bundibugyo Ebola Vaccine Trial Begins as Outbreak Death Toll Passes 700

World’s First Bundibugyo Ebola Vaccine Trial Begins as Outbreak Death Toll Passes 700

July 14, 2026
The world’s first clinical trial of a vaccine targeting the Bundibugyo str
Nine MENA Countries Advance National Meningitis Action Plans at WHO Cairo Workshop

Nine MENA Countries Advance National Meningitis Action Plans at WHO Cairo Workshop

July 9, 2026
WHO EMRO Accelerates Action Against Meningitis Countries across the WHO Eastern